Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-10-22 00:00:00 ET · period of report 2025-10-20 · accession 0001464583-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-22 | 2025-10-20 | KNSA | Megna Michael R | CAO | M - OptEx | $11.59 | +39.4K | 77.5K | +104% | +$457.0K |
| DM | 2025-10-22 | 2025-10-20 | KNSA | Megna Michael R | CAO | S - Sale+OE | $38.87 | -50.5K | 27.0K | -65% | -$1.96M |
| DM | 2025-10-22 | 2025-10-20 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -39.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-10-20 | M | A | 791 | $15.50 | 38,892 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-10-20 | M | A | 6,195 | $12.97 | 45,087 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-10-20 | M | A | 9,831 | $11.10 | 54,918 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-10-20 | M | A | 9,831 | $11.97 | 64,749 | D | — | — | |
| 5 | Common | Class A Ordinary Share | 2025-10-20 | M | A | 12,787 | $10.76 | 77,536 | D | — | — | |
| 6 | Common | Class A Ordinary Share | 2025-10-20 | S | D | 37,255 | $38.72 | 40,281 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $38.14 and $39.135. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 7 | Common | Class A Ordinary Share | 2025-10-20 | S | D | 13,235 | $39.31 | 27,046 | D | — | — | (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $39.145 and $39.57. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 8 | Derivative | Share Option | 2025-10-20 | M | D | 791 | $0.00 | 0 | D | $15.50 · — to 2030-09-09 | 791 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 9 | Derivative | Share Option | 2025-10-20 | M | D | 6,195 | $0.00 | 0 | D | $12.97 · — to 2031-09-01 | 6,195 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 10 | Derivative | Share Option | 2025-10-20 | M | D | 9,831 | $0.00 | 0 | D | $11.10 · — to 2032-04-06 | 9,831 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 11 | Derivative | Share Option | 2025-10-20 | M | D | 9,831 | $0.00 | 0 | D | $11.97 · — to 2032-08-31 | 9,831 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |
| 12 | Derivative | Share Option | 2025-10-20 | M | D | 12,787 | $0.00 | 0 | D | $10.76 · — to 2033-03-31 | 12,787 Class A Ordinary Share | (F4) The option is fully vested and exercisable. |